Fladrafinil: general
Fladrafinil is a wakefulness-promoting agent related to modafinil[1]. It's the bis(4-fluorophenyl) analogue of adrafinil, with a fluorine atom added at the para position of each phenyl ring[2]. Laboratoire L. Lafon patented it in 1984[2], but it was never brought to market as a medicine[1]. What circulates now is sold online and used non-medically as a nootropic[1].
The main thing to know before anything else: fladrafinil is reported to work as a prodrug for flmodafinil — meaning once it's ingested, your body converts it, and it's flmodafinil's metabolites that turn up afterward[3]. You're not really dosing "fladrafinil" in isolation; you're dosing something that becomes a different, related compound inside you.
The human evidence behind this is thin. The only controlled human data on record comes from a single study in which six volunteers each took 20 mg of either flmodafinil or fladrafinil[3]. That's it — there's no established dosing range, duration, or onset time beyond that one data point, and nothing here should be read as filling that gap. Treat the absence of broader data as the operative fact: start far lower than feels sensible, don't use it alone, and don't combine it with other substances while you're still working out how it affects you.
Fladrafinil is known under several names and codes — CRL-40,941, fluorafinil, bisfluoroadrafinil, and others[4][1][5][2].
References
- 2-[[Bis(4-fluorophenyl)methyl]sulfinyl]-N-hydroxyacetamide - Chemical Details — EPA CompTox
- Fladrafinil (CRL-40,941): Evidence Ledger — Vialog
- Investigations Into the Metabolism and Elimination of Flmodafinil and Fladrafinil for Sports Drug Testing Purposes — Drug Testing and Analysis (Wiley)
- Fladrafinil | C15H13F2NO3S | CID 13316557 — PubChem (NIH)
- Fladrafinil — Wikipedia
Comments
Sign in to join the conversation.
No comments yet.